First Command Bank Mi Nk Therapeutics, Inc. Transaction History
First Command Bank
- $1.06 Billion
- Q2 2023
A detailed history of First Command Bank transactions in Mi Nk Therapeutics, Inc. stock. As of the latest transaction made, First Command Bank holds 1,031 shares of INKT stock, worth $917. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,031Holding current value
$917% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INKT
# of Institutions
36Shares Held
939KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA234KShares$208,4210.0% of portfolio
-
Longbow Finance Sa Lutry, V8167KShares$148,3320.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny105KShares$93,6520.0% of portfolio
-
Geode Capital Management, LLC Boston, MA88.9KShares$79,0810.0% of portfolio
-
Black Rock Inc. New York, NY76.1KShares$67,7710.0% of portfolio
About MiNK Therapeutics, Inc.
- Ticker INKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,775,100
- Market Cap $30.1M
- Description
- MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...